SCP-9592
Safe
~
medium confidence
SCP-9592
Expected annual
$341K
One-time setup
$339K
Annual recurring
$336K
Personnel
1.47
Initial startup and analytical setup are moderate (~$339,000 one-time), while annual operations are driven by staff allocations, contingency reserves, sequencing/analysis, and medical/psychological support (~$335,600/yr). Main drivers: personnel wages, incident contingency, and recurring research/monitoring.
One-Time Capital Costs
Total: $339K
Annual Recurring Costs
Total: $336K/yr
Cost Scenarios
📊
Baseline
(baseline)
$336K/yr
Normal operational year with scheduled testing and no major incidents.
routine_testing
no_medical_emergencies
no large-scale incidents
🚨
Minor Incident
$376K/yr
One or more minor adverse events requiring emergency response, medical treatment, and increased PR/legal outlays.
ambulance_use
short-term hospitalization
property/cover reimbursements
🚨
Major Medical Incident
$486K/yr
Severe adverse reaction or containment-related medical crisis requiring extended care, large incident response and use of contingency reserves.
severe_injury
extended_hospitalization
major_containment_response
Personnel
1.47 total
| Role | Count | Notes |
|---|---|---|
| Research Scientist | 1 | Primary 1.0 FTE research scientist for day-to-day experiments and record-keeping. [#4] |
| Supervising Researcher | 0.1 | Combined pro-rated allocation equal to ~0.10 FTE (two supervisors each devoting ~5% of time) for approvals and oversight; cost accounted in staff_wages. [#3] |
| Security Officer / MTF Agent | 0.27 | Partial security allocation (~0.27 FTE equivalent) to cover controlled access/transfers and presence during tests; cost accounted in staff_wages. [#5] |
| Medical Officer / Nurse (on-call) | 0.1 | Part-time medical support (~0.10 FTE equivalent) for oversight of tests and on-call response; cost accounted in staff_wages. [#6] |
Confidence Notes
Estimates are based directly on analyst line items and reasonable midpoints but depend on assumed testing frequency (analyst used ~50 tests/yr for several items) and choices about contingency sizing; some items (ambulance usage, animal testing scope, catastrophic reserve use) remain uncertain.